Inventor
BANNEN LYNNE CANNE
US20 patents
⚠️ This page may combine multiple inventors who share the name “BANNEN LYNNE CANNE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
EXELIXIS INC
9 patentsUS7579473B2Aug 25, 2009
c-Met modulators and methods of use
EXELIXIS INC95 citations98
US7989622B2Aug 2, 2011
Phosphatidylinositol 3-kinase inhibitors and methods of their use
EXELIXIS INC64 citations97
US7977345B2Jul 12, 2011
c-MET modulators and method of use
EXELIXIS INC48 citations93
US11124482B2Sep 21, 2021
C-met modulators and methods of use
EXELIXIS INC6 citations83
US11708367B2Jul 25, 2023
Compounds for the treatment of kinase-dependent disorders
EXELIXIS INC2 citations72
US11542259B2Jan 3, 2023
Compounds for the treatment of kinase-dependent disorders
EXELIXIS INC3 citations72
US12195475B2Jan 14, 2025
Compounds for the treatment of kinase-dependent disorders
EXELIXIS INC0 citations62
US12503438B2Dec 23, 2025
Compounds for the treatment of kinase-dependent disorders
EXELIXIS INC0 citations51
US11673897B2Jun 13, 2023
Compounds for the treatment of kinase-dependent disorders
EXELIXIS INC0 citations51
BANNEN LYNNE CANNE
5 patentsUS9174947B2Nov 3, 2015
c-Met modulators and methods of use
BANNEN LYNNE CANNE45 citations97
US8497284B2Jul 30, 2013
C-met modulators and method of use
BANNEN LYNNE CANNE60 citations97
US8476298B2Jul 2, 2013
c-Met modulators and method of use
BANNEN LYNNE CANNE39 citations96
US8178532B2May 15, 2012
c-Met modulators and method of use
BANNEN LYNNE CANNE46 citations96
US8067436B2Nov 29, 2011
c-Met modulators and methods of use
BANNEN LYNNE CANNE59 citations96